Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25126846 | 0.87 | PTAFR (0.31) | — | |
| SCHEMBL25126829 | 0.86 | CYP26A1 (0.32) | — | |
| SCHEMBL29292631 | 0.84 | SLC2A1 (0.36) | AKR1C3AKR1C2 | |
| SCHEMBL25126778 | 0.84 | RXRA (0.32) | — | |
| SCHEMBL21846305 | 0.80 | RXRA (0.37) | — | |
| SCHEMBL25128679 | 0.79 | CYP26A1 (0.34) | — | |
| SCHEMBL25127093 | 0.79 | — | — | |
| SCHEMBL25127077 | 0.78 | KDM4E (0.32) | — | |
| SCHEMBL22600042 | 0.76 | RXRA (0.30) | — | |
| SCHEMBL23589607 | 0.75 | AKR1C3 (0.36) | AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | LAGE3, ELOC, ELOB | AKR1C3 1635/4885AKR1C2 1740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.